<?xml version="1.0" encoding="UTF-8"?>
<p>Similarly, the Drug Enforcement Administration has waived a requirement that patients who wish to begin buprenorphine treatment have an in-person consultation with the prescriber. This change permits individuals seeking buprenorphine treatment to be prescribed the medication after consulting with a waivered prescriber via telemedicine, without having to physically visit the provider's office. As with the modification to methadone access requirements, this innovation is in effect only for the duration of the COVID-19 public health emergency.
 <sup>
  <xref rid="R12" ref-type="bibr">12</xref>
 </sup>
</p>
